Previous Syphilis Alters the Course of Subsequent Episodes of Syphilis.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
01 03 2022
Historique:
received: 29 03 2021
pubmed: 18 5 2021
medline: 15 3 2022
entrez: 17 5 2021
Statut: ppublish

Résumé

The influence of previous syphilis on the course of a subsequent episode is unknown. Individuals enrolled in a study of cerebrospinal fluid (CSF) abnormalities in syphilis were allowed to enroll in the study again with subsequent syphilis. For each participant, the index episode was defined as the most recent syphilis episode for which the study entry visit was performed within 30 days of the syphilis diagnosis date. Venipuncture and lumbar puncture (LP) were performed. Total number of syphilis episodes was determined by review of medical and public health records. T. pallidum DNA in blood and rRNA in CSF were detected by polymerase chain reaction (PCR) and reverse transcriptase PCR. Odds ratios (ORs) with 95% confidence intervals (95% CI) were determined by logistic regression. 651 individuals had one (n = 482), two (n = 121) or three or more (n = 48) episodes of syphilis. The proportion of individuals whose index episode was early latent stage was significantly higher in those with ≥3 syphilis episodes; this relationship was reduced to a trend when rate of testing was taken into account. Adjusted odds (aOR) of detection of T. pallidum DNA in blood or rRNA in CSF at the index episode were significantly lower in those with previous syphilis (0.17 [95% CI, 0.09-0.31] and 0.15 [95% CI, 0.07-0.35]). The aOR for neurosyphilis at the index episode was also significantly lower in individuals with previous syphilis (0.54 [95% CI, 0.34-0.87]). Previous syphilis attenuates the manifestations of subsequent infection with T. pallidum.

Sections du résumé

BACKGROUND
The influence of previous syphilis on the course of a subsequent episode is unknown.
METHODS
Individuals enrolled in a study of cerebrospinal fluid (CSF) abnormalities in syphilis were allowed to enroll in the study again with subsequent syphilis. For each participant, the index episode was defined as the most recent syphilis episode for which the study entry visit was performed within 30 days of the syphilis diagnosis date. Venipuncture and lumbar puncture (LP) were performed. Total number of syphilis episodes was determined by review of medical and public health records. T. pallidum DNA in blood and rRNA in CSF were detected by polymerase chain reaction (PCR) and reverse transcriptase PCR. Odds ratios (ORs) with 95% confidence intervals (95% CI) were determined by logistic regression.
RESULTS
651 individuals had one (n = 482), two (n = 121) or three or more (n = 48) episodes of syphilis. The proportion of individuals whose index episode was early latent stage was significantly higher in those with ≥3 syphilis episodes; this relationship was reduced to a trend when rate of testing was taken into account. Adjusted odds (aOR) of detection of T. pallidum DNA in blood or rRNA in CSF at the index episode were significantly lower in those with previous syphilis (0.17 [95% CI, 0.09-0.31] and 0.15 [95% CI, 0.07-0.35]). The aOR for neurosyphilis at the index episode was also significantly lower in individuals with previous syphilis (0.54 [95% CI, 0.34-0.87]).
CONCLUSIONS
Previous syphilis attenuates the manifestations of subsequent infection with T. pallidum.

Identifiants

pubmed: 33999990
pii: 6277029
doi: 10.1093/cid/ciab287
pmc: PMC8886916
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1-e5

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS034235
Pays : United States

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Dermatology. 2015;230(4):302-7
pubmed: 25823442
Sex Transm Dis. 2011 Jan;38(1):12-7
pubmed: 20739912
Sex Transm Dis. 2018 Sep;45(9):e68-e71
pubmed: 29543622
Sex Transm Dis. 2009 Jun;36(6):331-5
pubmed: 19556925
MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137
pubmed: 26042815
BMJ Open. 2018 Jul 10;8(7):e021544
pubmed: 29991630
Sex Health. 2015 Apr;12(2):155-63
pubmed: 25607751
Monogr Ser World Health Organ. 1957;(35):3-266
pubmed: 13423342
Medicine (Baltimore). 1956 Feb;35(1):33-82
pubmed: 13296652
J Infect Dis. 2016 Apr 15;213(8):1348-54
pubmed: 26655298
Open Forum Infect Dis. 2018 Apr 28;5(6):ofy096
pubmed: 29977956
Clin Infect Dis. 2018 Feb 10;66(5):811-812
pubmed: 29045594
Nature. 2005 Jan 27;433(7024):417-21
pubmed: 15674292
J Infect Dis. 2004 Feb 1;189(3):369-76
pubmed: 14745693
J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1791-1795
pubmed: 29775498
Sex Transm Infect. 2018 May;94(3):180-186
pubmed: 29021408
Clin Infect Dis. 2017 Aug 1;65(3):389-395
pubmed: 28419198
LGBT Health. 2017 Jun;4(3):232-236
pubmed: 27991843
Clin Infect Dis. 2010 Oct 15;51(8):976-9
pubmed: 20825309

Auteurs

Christina M Marra (CM)

University of Washington School of Medicine, Department of Neurology, Seattle, WA, USA.
Medicine (Infectious Diseases), Seattle, WA, USA.

Clare L Maxwell (CL)

University of Washington School of Medicine, Department of Neurology, Seattle, WA, USA.

Sharon K Sahi (SK)

University of Washington School of Medicine, Department of Neurology, Seattle, WA, USA.

Lauren C Tantalo (LC)

University of Washington School of Medicine, Department of Neurology, Seattle, WA, USA.

Shelia B Dunaway (SB)

Medicine (Infectious Diseases), Seattle, WA, USA.

Sheila A Lukehart (SA)

Medicine (Infectious Diseases), Seattle, WA, USA.
Global Health, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH